Weiss Multi-Strategy Advisers’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-58,124	Closed	-$478K	–	822
2022 Q3	$478K	Sell	58,124 -2,876	-5%	-$22.1K	0.01%	555
2022 Q2	$400K	Sell	61,000 -4,488	-7%	-$21.7K	0.01%	562
2022 Q1	$366K	Sell	65,488 -1,156	-2%	-$4.76K	0.01%	589
2021 Q4	$313K	Buy	66,644 +14,644	+28%	+$90.8K	0.01%	586
2021 Q3	$321K	Buy	52,000 +27,050	+108%	+$162K	0.01%	600
2021 Q2	$164K	Buy	24,950 +894	+4%	+$6.16K	﹤0.01%	636
2021 Q1	$176K	Buy	+24,056	New	+$208K	﹤0.01%	662
2019 Q1	–	Sell	-1,000	Closed	-$16K	–	653
2018 Q4	$16K	Sell	1,000 -500	-33%	-$11K	﹤0.01%	436
2018 Q3	$50K	Buy	+1,500	New	+$38.6K	﹤0.01%	499
2014 Q1	–	Sell	-4,762	Closed	-$87K	–	1177
2013 Q4	$87K	Buy	+4,762	New	+$95.4K	﹤0.01%	951

Other funds holding AVEO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AVEO Position: Q4 2022 in Review

Weiss Multi-Strategy Advisers sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 58,124 shares — an estimated $478K sold.

Weiss Multi-Strategy Advisers first reported a position in AVEO in Q4 2013 and held it in 10 quarters. The position peaked at $478K in Q3 2022. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

Weiss Multi-Strategy Advisers reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 58,124 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $478K.
Weiss Multi-Strategy Advisers first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2013 and held it in 10 quarters.
Weiss Multi-Strategy Advisers's AVEO Pharmaceuticals, Inc. position peaked at $478K in Q3 2022.
110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.